Showing results (141-150 of 329) with videos related to
Sort By:
Pageof 33
Frontiers in Neurology|December 1, 2018
A Chromosomal Deletion and New Frameshift Mutation Cause ARSACS in an African-AmericanSean C Dougherty, Amy Harper, Hind Al Saif, et al.Journal of Advanced Nursing|January 26, 2011
Analysis of international content of ranked nursing journals in 2005 using ex post facto designMolly C Dougherty, Shu-Yuan Lin, Hugh P McKenna, et al.Clinical Case Reports|October 15, 2025
Relapsed Chronic Lymphocytic Leukemia Heralded by Parathyroid Hormone Related Peptide-Mediated HypercalcemiaSrikar Tallavajhala, Joanna Lee, Sean C Dougherty, et al.Current Medical Research and Opinion|June 3, 2008
The effect of severe hepatic impairment on the pharmacokinetics and haematological response of C.E.R.AViera Kupcová, Jan Sperl, Anne Pannier, et al.Oncology Reports|June 19, 1998
Adeno-associated virus vector mediated transduction of primary normal human breast epithelial cellsJ Yang, Y Hirokawa, C Dougherty, et al.Bone Marrow Transplantation|January 1, 1989
Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantationH C Schouten, J O Armitage, L W Klassen, et al.Journal of Clinical Pharmacology|October 27, 2007
Pharmacokinetic and pharmacodynamic properties of methoxy polyethylene glycol-epoetin beta are unaffected by the site of subcutaneous administrationSteven Fishbane, Anne Pannier, Xavier Liogier, et al.The American Journal of Clinical Nutrition|June 1, 1991
Twin pregnancy: the impact of the Higgins Nutrition Intervention Program on maternal and neonatal outcomesS Dubois, C Dougherty, M P Duquette, et al.Human Gene Therapy|July 26, 2000
A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplantsK G Lucas, Q Sun, R L Burton, et al.Cancer|September 1, 1990
Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantationW D Haire, R P Lieberman, J Edney, et al.Pageof 33